Announcements Trials

Browse Landscape

Phase

Phase 2 27 Phase 3 20 Phase NA 6 Phase 1 4 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

INDUSTRY 213 OTHER 132 NIH 23 UNKNOWN 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 10 Breast Neoplasms 9 Central Nervous System Neoplasms 8 Multiple Myeloma 7 Lung Neoplasms 7 Leukemia, Myeloid, Acute 6 Ovarian Neoplasms 5 Uterine Cervical Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Non-Hodgkin 4 Leukemia 4 Gliosarcoma 4 Glioblastoma 4 Burkitt Lymphoma 4 Squamous Cell Carcinoma of Head and Neck 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Congenital Abnormalities 3 Colorectal Neoplasms 3 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Recurrence 2 Radiation Injuries 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Oligodendroglioma 2 Neuroblastoma 2 Myelodysplastic Syndromes 2 Lymphoma 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2

Interventions

pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × NETWORK × Neoplasm Metastasis × Clear all

NCT02129556 2019-02-15

PANACEA

ETOP IBCSG Partners Foundation

Phase 1/2 Completed

58 enrolled 16 charts

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡